Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2013 2
2014 3
2015 6
2016 9
2017 6
2018 10
2019 8
2020 9
2021 11
2022 14
2023 12
2024 18
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis.
Siciliano MA, Caridà G, Ciliberto D, d'Apolito M, Pelaia C, Caracciolo D, Riillo C, Correale P, Galvano A, Russo A, Barbieri V, Tassone P, Tagliaferri P. Siciliano MA, et al. Among authors: galvano a. ESMO Open. 2022 Jun;7(3):100465. doi: 10.1016/j.esmoop.2022.100465. Epub 2022 Apr 12. ESMO Open. 2022. PMID: 35427835 Free PMC article.
Neuropathic pain, antidepressant drugs, and inflammation: a narrative review.
Catalisano G, Campione GM, Spurio G, Galvano AN, di Villalba CP, Giarratano A, Alongi A, Ippolito M, Cortegiani A. Catalisano G, et al. Among authors: galvano an. J Anesth Analg Crit Care. 2024 Sep 27;4(1):67. doi: 10.1186/s44158-024-00204-z. J Anesth Analg Crit Care. 2024. PMID: 39334307 Free PMC article. Review.
The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols.
Di Fede O, Canepa F, Panzarella V, Mauceri R, Del Gaizo C, Bedogni A, Fusco V, Tozzo P, Pizzo G, Campisi G, Galvano A. Di Fede O, et al. Among authors: galvano a. Int J Environ Res Public Health. 2021 Aug 10;18(16):8432. doi: 10.3390/ijerph18168432. Int J Environ Res Public Health. 2021. PMID: 34444181 Free PMC article.
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis.
Staropoli N, Ciliberto D, Luciano F, Napoli C, Costa M, Rossini G, Arbitrio M, Labanca C, Riillo C, Del Giudice T, Crispino A, Salvino A, Galvano A, Russo A, Tassone P, Tagliaferri P. Staropoli N, et al. Among authors: galvano a. Crit Rev Oncol Hematol. 2024 Jan;193:104229. doi: 10.1016/j.critrevonc.2023.104229. Epub 2023 Dec 7. Crit Rev Oncol Hematol. 2024. PMID: 38065404 Free article.
PROTACs: The Future of Leukemia Therapeutics.
Anwar Z, Ali MS, Galvano A, Perez A, La Mantia M, Bukhari I, Swiatczak B. Anwar Z, et al. Among authors: galvano a. Front Cell Dev Biol. 2022 Sep 2;10:851087. doi: 10.3389/fcell.2022.851087. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36120561 Free PMC article. Review.
Network approach in liquidomics landscape.
Santini D, Botticelli A, Galvano A, Iuliani M, Incorvaia L, Gristina V, Taffon C, Foderaro S, Paccagnella E, Simonetti S, Fazio F, Scagnoli S, Pomati G, Pantano F, Perrone G, De Falco E, Russo A, Spinelli GP. Santini D, et al. Among authors: galvano a. J Exp Clin Cancer Res. 2023 Aug 4;42(1):193. doi: 10.1186/s13046-023-02743-9. J Exp Clin Cancer Res. 2023. PMID: 37542343 Free PMC article. Review.
How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials.
Santini D, Galvano A, Pantano F, Incorvaia L, Rizzo S, Vincenzi B, Castellana L, Giuliana G, Guadagni F, Toia F, Tonini G, Russo A, Badalamenti G, Bazan V. Santini D, et al. Among authors: galvano a. Crit Rev Oncol Hematol. 2019 Oct;142:68-75. doi: 10.1016/j.critrevonc.2019.07.013. Epub 2019 Jul 25. Crit Rev Oncol Hematol. 2019. PMID: 31377434
110 results